Suppliers / Arthur Group

Arthur Group

China Updated 9 July 2026

Arthur Group is an API and finished-dose manufacturer based in China. It holds 3 active US drug master files across a filed portfolio of 3 molecules.

3
active US DMFs
0
valid CEPs
0
registered plants
1
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Azacitidine US FDA 1
Bortezomib US FDA 1
Busulfan US FDA 1

Also appears on these molecule pages

Azacitidine API Bortezomib API Busulfan API Melphalan finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 1 None

Questions about Arthur Group

Does Arthur Group hold a US DMF or a CEP?
Arthur Group holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Arthur Group make?
3 molecules are on record against Arthur Group, including Azacitidine, Bortezomib and Busulfan. Each links through to that molecule's full manufacturer list.
Where does Arthur Group file?
Filings are on record with US FDA, 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Arthur Group comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Shilpa Pharma Lifesciences shares 3 molecules MSN Laboratories shares 2 molecules Hetero shares 2 molecules Dr Reddy's Laboratories shares 2 molecules Laurus Labs shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability